You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Price Trends for WESNATE DHA SOFTGEL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for WESNATE DHA SOFTGEL

Average Pharmacy Cost for WESNATE DHA SOFTGEL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
WESNATE DHA SOFTGEL 69367-0317-30 1.28640 EACH 2026-03-18
WESNATE DHA SOFTGEL 69367-0317-30 1.27247 EACH 2026-02-18
WESNATE DHA SOFTGEL 69367-0317-30 1.31504 EACH 2026-01-21
WESNATE DHA SOFTGEL 69367-0317-30 1.34775 EACH 2025-12-17
WESNATE DHA SOFTGEL 69367-0317-30 1.44926 EACH 2025-11-19
WESNATE DHA SOFTGEL 69367-0317-30 1.52786 EACH 2025-10-22
WESNATE DHA SOFTGEL 69367-0317-30 1.58827 EACH 2025-09-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for WESNATE DHA Softgel

Last updated: February 24, 2026

What is WESNATE DHA Softgel?

WESNATE DHA Softgel is a dietary supplement containing docosahexaenoic acid (DHA). It is marketed primarily for brain health, prenatal nutrition, and cardiovascular benefits. The softgel formulation enhances bioavailability and ease of ingestion.

Market Overview

Market Size and Growth

  • The global omega-3 fatty acids market was valued at approximately USD 4.2 billion in 2021.
  • Compound annual growth rate (CAGR): 8.5% (2022-2027).
  • Euromonitor projects the omega-3 segment to reach USD 6.5 billion by 2027.

Key Market Segments

  • Dietary supplements: 55% of total omega-3 revenue.
  • Pharmaceuticals: 30%.
  • Food fortification: 15%.

Consumer Trends

  • Increasing awareness of prenatal supplement needs.
  • Growing popularity of plant-based and sustainably sourced omega-3s.
  • Rising demand in emerging markets with expanding healthcare access.

Competitive Landscape

  • Major brands: Nordic Naturals, Nordic Naturals, Minami, Now Foods, and Solgar.
  • Predominant sourcing: Fish oil, algal oil.
  • Differentiation factors: Purity, sustainability, omega-3 concentration, and delivery format.

Price Point and Distribution

Current Retail Pricing

  • WESNATE DHA Softgel retail price (average): USD 20 - USD 35 per bottle (30-60 softgels).
  • Price varies based on potency, source (fish vs. algae), and brand positioning.

Wholesale Pricing and Margin Expectations

  • Wholesale: USD 10 - USD 17 per bottle.
  • Typical retail markup: 50% to 100%.
  • Pharmacies and health stores: Higher margins; e-commerce channels: more competitive pricing.

Regulatory Environment

  • Generally classified as dietary supplements in North America and Europe.
  • Regulatory oversight varies by region; in the U.S., the Food and Drug Administration (FDA) monitors structure/function claims.
  • GMP compliance critical for market credibility.

Price Projections (2023–2028)

Year Estimated Retail Price (USD) Factors Affecting Price Comments
2023 20 – 35 Ingredient costs, demand, sourcing Slight price stabilization expected
2024 21 – 37 Rising raw material costs, inflation Slight increase predicted
2025 22 – 40 Sourcing challenges, premium branding Price premium for high-quality sourcing
2026 23 – 42 Competitive pressure, consolidation Marginal price increases
2027 24 – 45 Eco-friendly sourcing trends Potential premium for sustainability

Factors Influencing Price Trends:

  • Raw material costs: Fish oil and algal sources fluctuate due to supply chain and environmental factors.
  • Regulatory changes: Stricter quality and safety standards could increase manufacturing costs.
  • Consumer preferences: Preference for sustainably sourced, high-potency formulations drives premium pricing.
  • Competitive landscape: Entry of private label brands lowers overall pricing.

Key Opportunities and Risks

Opportunities

  • Growing demand in Asia-Pacific and Latin America.
  • Increased product differentiation via sourcing transparency and sustainability.
  • Expanding presence in pharmaceuticals for adjunct therapy.

Risks

  • Price erosion from private label and generic products.
  • Supply chain disruptions affecting raw material costs.
  • Regulatory shifts increasing compliance costs.

Summary

WESNATE DHA Softgel exists within a competitive, rapidly growing market. Pricing remains stable but is subject to raw material costs, regulatory environment, and consumer trends. Future pricing is likely to increase gradually, driven by demand for high-quality, sustainably sourced DHA products.

Key Takeaways

  • The global omega-3 market is expanding at nearly 9% CAGR through 2027.
  • WESNATE DHA Softgel retail prices are currently USD 20 - USD 35.
  • Prices are expected to rise modestly, averaging USD 24 - USD 45 by 2027.
  • Competition focuses on ingredient purity, sustainability, and delivery format.
  • Market growth is supported by increasing health awareness and dietary supplement consumption.

Frequently Asked Questions

1. What factors influence the retail price of WESNATE DHA Softgel?
Raw ingredient costs, demand, sourcing quality, regulatory compliance, and branding influence pricing.

2. How does sourcing impact the price of DHA in supplements?
Marine-derived DHA typically costs more than plant-based sources. Sustainable and high-purity sourcing commands a premium.

3. What regions are seeing the fastest growth for DHA supplements?
Asia-Pacific and Latin America are experiencing rapid growth due to rising health awareness and increasing disposable incomes.

4. How could regulatory changes impact market prices?
Stricter safety standards and quality controls could increase manufacturing costs and retail prices.

5. What is the outlook for private label brands in this market?
Private label brands are expected to increase competitiveness, potentially lowering average retail prices.


References

[1] Euromonitor International. (2022). Omega-3 Fatty Acids Market Report.
[2] MarketsandMarkets. (2022). Omega-3 Market by Source, Application & Geography.
[3] U.S. Food and Drug Administration. Guidance for Industry: Labeling of Dietary Supplements.
[4] IBISWorld. (2022). Dietary Supplements Industry Report.
[5] Allied Market Research. (2022). DHA and EPA Market Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.